
|Videos|February 9, 2015
How Will Biosimilars Impact the US?
Raulo Frear, PharmD, general manager of OmedaRx, discusses the ramifications of biosimilars hitting the US market.
Advertisement
Raulo Frear, PharmD, general manager of OmedaRx, discusses the ramifications of biosimilars hitting the US market.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
3
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
4
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
5














































































































































































































